Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment

PHASE4CompletedINTERVENTIONAL
Enrollment

347

Participants

Timeline

Start Date

June 9, 2016

Primary Completion Date

August 4, 2017

Study Completion Date

June 8, 2018

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

nintedanib

DRUG

placebo

Trial Locations (86)

1070

ULB Hopital Erasme, Brussels

1125

Semmelweis University, Budapest

2050

Royal Prince Alfred Hospital, Camperdown, Sydney

2139

Concord General Repatriation Hospital -Ambulatory Care Unit, Concord

2650

Edegem - UNIV UZ Antwerpen, Edegem

3000

UZ Leuven, Leuven

3004

The Alfred Hospital, Melbourne

3526

BAZ County Central Hospital and University Teaching Hospital, Miskolc

4000

Centre Hospitalier Universitaire de Liège, Liège

5000

Royal Adelaide Hospital, Adelaide

5530

Yvoir - UNIV UCL de Mont-Godinne, Yvoir

6772

Csongrad County's Hosp., Deszk

8582

Pulmonology Institute of Veszprem County, Farkasgyepu, Farkasgyepű

13620

Seoul National University Bundang Hospital, Seongnam

14059

Thomayer Hospital, Prague

14165

Helios Klinikum Emil von Behring, Berlin

17475

Universitätsmedizin Greifswald, Greifswald

20520

TYKS, Keuhkosairauksien klinikka, Turku, Turku

22927

Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH, Großhansdorf

23225

Pulmonary Associates of Richmond, Inc., Richmond

28006

Hospital La Princesa, Madrid

28040

Fundación Jiménez Díaz, Madrid

Hospital Clínico San Carlos, Madrid

28220

Hospital Puerta de Hierro, Majadahonda (Madrid)

28223

Hospital Quirónsalud Madrid, Pozuelo de Alarcón

29609

HOP de la Cavale Blanche, Brest

30599

University Hospital Plzen, Plzen-Bory, Pilsen

30625

Medizinische Hochschule Hannover, Hanover

32209

University of Florida College of Medicine, Jacksonville

33765

St. Francis Medical Institute, Clearwater

34376

Lungenfachklinik Immenhausen, Immenhausen

35033

HOP Pontchaillou, Rennes

35392

Universitätsklinikum Gießen und Marburg GmbH, Giessen

35501

Jasper Summit Research, LLC, Jasper

37044

HOP Bretonneau, Tours

41013

Hospital Virgen del Rocío, Seville

45409

Clinical Research Solutions, Dayton

46010

Hospital Clínico de Valencia, Valencia

46017

Hospital Dr. Peset, Valencia

48149

Universitätsklinikum Münster, Münster

48960

Hospital de Galdakao, Galdakao

51092

HOP Maison Blanche, Reims

55407

Minnesota Lung Center, Minneapolis

63017

The Lung Research Center, LLC, Chesterfield

67091

HOP Civil, Strasbourg

69126

Thoraxklinik-Heidelberg gGmbH am Universitätsklinikum Heidelberg, Heidelberg

69677

HOP Louis Pradel, Bron

70210

KYS, Keuhkosairauksien, Kuopio

75015

HOP Européen G. Pompidou, Paris

81377

Klinikum der Universität München - Campus Großhadern, München

85065

Our Doctor Clinical Trial Center, Department in Bydgoszcz, Bydgoszcz

90220

OYS, sisätautien klinikka, Oulu

96049

CIMS Studienzentrum Bamberg GmbH, Bamberg

06810

Western Connecticut Medical Group, Danbury

779 00

University Hospital Olomouc, Olomouc

180 81

University Hospital Na Bulovce, Prague, Prague

401 13

Masaryk Hospital, Usti nad Labem, Ústí nad Labem

00290

HYKS Keuhkosairauksien, Helsinki

FI-33520

Tampere University Hospital, Tampere

489-8642

Tosei General Hospital, Aichi, Seto

830-0011

Kurume University Hospital, Fukuoka, Kurume

319-1113

Ibarakihigashi National Hospial, Ibaraki, Naka-gun

236-0051

Kanagawa Cardiovascular and Respiratory Center, Kanagawa, Yokohama

589-8511

Kindai University Hospital, Osaka, Osakasayama

591-8555

National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Sakai

770-8503

Tokushima University Hospital, Tokushima, Tokushima

113-8603

Nippon Medical School Hospital, Tokyo, Bunkyo-ku

143-8541

Toho University Omori Medical Center, Tokyo, Ota-ku

162-8655

Global Health and Medicine Ctr, Tokyo, Shinjuku-ku

40-752

Non-pub.Health Care NZOZ Profilaktyka W. Pierzchala,Katowice, Katowice

31-066

Univ. Hospital in Krakow,Pulmonology Clinical Dept, Krakow

31-202

John Paul II Cracovian Hosp, Krakow

90-153

Norbert Barlicki University Clinical Hospital No.1, Lodz, Lodz

87-100

"Practice of Internists Nasz Lekarz, Torun", Torun

03080

Seoul National University Hospital, Seoul

05505

Asan Medical Center, Seoul

08036

Hospital Clínic de Barcelona, Barcelona

08041

Hospital Santa Creu i Sant Pau, Barcelona

08907

Hospital de Bellvitge, L'Hospitalet Llobregat (bcn)

08208

CS Parc Taulí, Sabadell

BS10 5NB

Southmead Hospital, Bristol

CB23 3RE

Papworth Hospital, Cambridge

EX2 5DW

Royal Devon and Exeter Hospital, Exeter

SW3 6NP

Royal Brompton Hospital, London

M23 9LT

Wythenshawe Hospital, Manchester

OX3 7LE

Churchill Hospital, Oxford

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02788474 - Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment | Biotech Hunter | Biotech Hunter